Skip to main content
Equibles
NGVT logo

NGVT · Ingevity Corp

Track NGVT — free

Use NGVT with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research NGVT.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$61.72 -0.25 (-0.40%) At close · Nov 13
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$2.08B
Shares
33.78M
Volume · Nov 13 233.97K Avg daily vol (3M) 298.49K

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$61.72 Open$62.29 Day$61.10–62.29 52W close$47.12–77.87 Avg vol 30d356K Short int1.3M · 3.7% of shares · 4.4d Short vol63% Last earningsNov 5, 2026 DataJan 2020–Nov 2026 Filing10-Q · Nov 5

Up next

Next earnings call
Feb 25, 2027 Est · unconfirmed · in 15 wks
Q3 2026 earnings call transcript
call held Nov 5, 2026
Play latest call

Latest documents

2026
Nov 5
Quarterly report 10-Q FY2026 Q3, ended Sep 30
Net income rose as sales declined and outlook narrowed

Ingevity Corporation reported net income of $49.3 million for the three months ended September 30, 2026, versus $43.5 million in 2025, while net sales declined to $305.1 million from $333.1 million. Full-year adjusted EBITDA guidance is $385 million to $395 million.

Revenue $305.1M ▼ 8.4% Net income $49.3M ▲ 13.3% Diluted EPS $1.41 ▲ 19.5%
Read from the MD&A section
6 source passages
Ingevity Corporation provides products and technologies that purify, protect, and enhance the world around us. #### Three Months Ended September 30, 2026 vs. 2025 | Net sales | 305.1 | 333.1 | 877.2 | 912.5 | | Net income (loss) | 49.3 | 43.5 | 144.4 | (82.5) | We are narrowing our full-year adjusted EBITDA outlook, while maintaining the midpoint of the prior range, supported by solid year-to-date performance and increased visibility into expected results for the remainder of the year. Adjusted EBITDA is expected to be between $385 million and $395 million for 2026. Open the document at this passage
Nov 5
Earnings call
Adjusted EBITDA outlook narrowed; buybacks and EPS rise

Ingevity narrowed full-year adjusted EBITDA guidance to $385 million to $395 million. Third-quarter adjusted EPS rose approximately 24% to $1.63, and $39 million in shares were repurchased.

4 source passages
Ingevity is becoming a stronger, more focused company with resilient margins, strong cash generation. Differentiated technologies, and multiple paths to organic growth. With three-quarters of the year behind us, we are narrowing our full-year adjusted EBITDA outlook to $385 million to $395 million, maintaining the $390 million midpoint of our prior range. Adjusted earnings per share was $1.63 compared to $1.31 in the prior year quarter, an increase of approximately 24%. We repurchased approximately $39 million of shares during the quarter, bringing year-to-date repurchases to approximately $125 million, with $172 million of capacity remaining on our current authorization. Open the document at this passage
Nov 4
Current report 8-K
Third-quarter earnings rise as adjusted EBITDA outlook narrows

Ingevity reported third-quarter net sales of $305.1 million, down 8%, and net income from continuing operations of $51.1 million, or $1.46 per diluted share. It narrowed 2026 adjusted EBITDA guidance to $385 million to $395 million.

Financial results
4 source passages
Net sales of $305.1 million decreased 8% from prior year; excluding Road Markings, sales increased 2% Net income from continuing operations of $51.1 million, or $1.46 per diluted share, compared to $40.8 million, or $1.10 per diluted share, in the prior year Narrows full year adjusted EBITDA outlook to a range of $385 million to $395 million, maintaining the midpoint of the prior range Ingevity Corporation (NYSE: NGVT) today reported its financial results for the third quarter of 2026. Open the document at this passage
Jul 30
Quarterly report 10-Q FY2026 Q2, ended Jun 30
Quarterly report for FY2026 Q2 AI summary on its way
Revenue $314.1M ▼ 5.2% Net income $35.3M Diluted EPS $1.00
All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$1.13B
Trailing 12 months
Net income (TTM)
$59.80M
Trailing 12 months
Revenue growth YoY
-8.4%
Year over year
Operating margin
35.9%
Trailing 12 months
P / E (TTM)
35.5
Trailing earnings · reciprocal yield 2.8%
FCF yield
5.9%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
−$1.06B
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
-5.7%
Year over year · fewer shares
Price change (1Y)
+22.1%
Trailing year
Short interest
3.7%
Latest settlement · 4.4 days to cover
View all 125 metrics

Quarterly results

Revenue Net income Net loss
· $135.60M $16.60M '24 Q4* ▼27.1% $247.90M $20.50M '25 Q1 ▼15.1% $331.50M −$146.50M '25 Q2 ▼0.2% $333.10M $43.50M '25 Q3 ▲88.1% $255.10M −$84.60M '25 Q4* ▲4.1% $258.00M $59.80M '26 Q1 ▼5.2% $314.10M $35.30M '26 Q2 LATEST ▼8.4% $305.10M $49.30M '26 Q3

* Q4 derived as the full year minus Q1 to Q3.

AI Brief

Q2 FY26 earnings call · Jul 30, 2026
Q2 FY26

TL;DR. Ingevity reported broad underlying growth and sharply higher profitability, with adjusted EBITDA up 14% to $115.0 million and margin expanding to 36.6%, while raising full-year adjusted EBITDA guidance to $380–$400 million. The second half is expected to be tempered by weaker North American auto production, planned plant outages, and a dynamic macroeconomic environment.

Bullish
  • + Sales excluding Road Markings increased 5%, with growth across all three segments.
  • + Performance Materials delivered 4% sales growth to $160.6 million and 6% EBITDA growth to $86.1 million, with margin expanding to 53.6%.
  • + Advanced Polymer Technologies sales increased 14% to $49.3 million and EBITDA rose to $11.2 million from $2.0 million.
Bearish
  • − Reported sales declined 5% to $314.1 million, primarily because of the Road Markings divestiture.
  • − Pavement Technologies EBITDA declined $3.4 million to $25.4 million because prior-year results included $6.0 million of Road Markings EBITDA.
  • − The company expects second-half Performance Materials profitability to face pressure from weaker auto production and planned maintenance outages.
  • − Pavement Technologies faced softer demand in China and South America as higher asphalt prices increased project costs and delayed projects.
  • − Advanced Polymer Technologies benefited from competitor supply disruptions that are expected to normalize.
  • − Second-quarter operating cash flow was negative $13.8 million after a $113.2 million litigation settlement payment.

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Sell Momentum Weak Sentiment Bullish Fundamentals Strong Quant / Vol High
Market backdrop VIX 19.3 · elevated Equity put/call 0.63
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −13%
below
Price vs 50-day avg −11%
below
RSI (14) 35
neutral
MACD trend Negative
52-week position 47%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Weak
1-month return −12%
trailing
6-month return −10%
trailing
YTD return +4%
this year
Relative strength −10%
vs S&P · 6-mo
Sentiment
smart money
Bullish
Trend (MA cross) No cross
50d $70 › 200d $71 — 200d above 50d
Institutional flow Accumulating
291 of 318 funds reported for Sep 30 · net +171.9K sh shares · +45 new
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
3.71% of shares out · ▼ -8.2% MoM · 4.4 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
318 holders — near 3-yr high, broad support
Squeeze score 47
elevated · 0–100
Fundamentals
Strong
Revenue growth −3%
Y/Y
Gross margin 40%
expanding
EPS growth +61%
Y/Y
Free cash flow $249.1M
Valuation P/E 35.5
in line
Buyback $172.2M
remaining
Balance sheet $1.1B
net debt
Quant / Vol
risk profile
High
Volatility 35%
annualized · 1-yr
Max drawdown −23%
past year
ATR 4.4%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Beat or met 3 of last 6
Latest guidance · from the Earnings Call filed Jul 30, 2026
Adjusted EBITDA · full year Non-GAAP $380M – $400M
Free cash flow · full year $220M – $245M
Previous outlook earlier release · from the 8-K filed Jul 29, 2026

Still-open targets the latest release did not restate under the same label.

Net sales · full year 2026 $1.05B – $1.15B
Adjusted EBITDA · full year 2026 $380M – $400M
Diluted adjusted EPS · full year 2026 $5.00 – $5.45
Guided vs delivered · last 6 settled
Sales Full Year 2025
guided $1.25B – $1.4B
$1.17B Miss −11.9%
Sales full year 2024
guided $1.4B – $1.5B
$1.2B Miss −17.2%
Sales full year 2023
guided $1.9B – $2.1B
$1.22B Miss −39.2%
Sales 2022
guided $1.53B – $1.65B
$1.67B Beat +5.1%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Sell
3 · 4 · 0
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−13% Bearish
Price vs 50-day avg
−11% Bearish
RSI (14)
35 Neutral
MACD trend
Negative Bearish
52-week position
47% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross) No cross
50d $70 › 200d $71 — 200d above 50d
Institutional flow Accumulating
291 of 318 funds reported for Sep 30 · net +171.9K sh shares · +45 new
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
3.71% of shares out · ▼ -8.2% MoM · 4.4 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
318 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $47 Now $62 · 47% Range high $78
vs 200-day avg -13% vs 50-day avg -11%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Adjusted EBITDA from continuing operations non-GAAP $115M Three Months Ended June 30, 2026 filing —
Advanced Polymer Technologies - Segment EBITDA $11.2M Three Months Ended June 30, 2026 filing —
Advanced Polymer Technologies - Segment EBITDA margin 22.7% Three Months Ended June 30, 2026 filing —
Pavement Technologies - Segment EBITDA $25.4M Three Months Ended June 30, 2026 filing —
Pavement Technologies - Segment EBITDA margin 24.4% Three Months Ended June 30, 2026 filing —
Performance Materials - Segment EBITDA $86.1M Three Months Ended June 30, 2026 filing —
Performance Materials - Segment EBITDA margin 53.6% Three Months Ended June 30, 2026 filing —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Specialty Chemicals — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
NGVT
Ingevity Corp
this stock
$2.08B +4.3% -2.7% 35.5 3.7%
LIN
Linde PLC
 $241.51B +23.4% +3.0% 34.9 1.4%
AIQUF
L Air Liquide SA
 $137.11B +14.4% — — 0.0%
ECL
Ecolab Inc.
 $86.74B +17.8% +2.2% 42.1 1.5%
SHW
Sherwin Williams Co
 $84.53B +8.0% +2.1% 32.2 2.5%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
346
% held
104.5%
Reported
291 of 318
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
345
View
Short & Settlement
Short Interest Falling
Shares short
1.3M
Days to cover
4.4d
Change
-111.4K sh
View
Short Volume
Short vol %
63%
As of
Nov 13, 2026
Short Total
View
Fails to Deliver
FTD shares
4.0K
Value
$288.9K
As of
Oct 9, 2026
View
Off-Exchange
Off-exchange %
36.4%
Week of
Oct 5, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$1.2B
Net income (FY)
$-167.1M
EPS diluted
$-4.61
View
Buybacks
Authorized
$500.0M
Remaining
$172.2M
Spent Remaining
View
Filings
SEC Filings
Latest
10-Q
Filed
Nov 5, 2026
This year
18

Ingevity Corporation reported net income of $49.3 million for the three months ended September 30, 2026, versus $43.5 million in 2025, while net sales declined to $305.1 million from $333.1 million. Full-year adjusted EBITDA guidance is $385 million to $395 million.

View
Proposed Sales
Value
$1.6M
Shares
20.1K
Filed
Aug 12, 2026
View
Earnings & Events
Webcasts
Last webcast
Nov 5, 2026
View
Investor Relations
Latest news
Ingevity reports third quarter 20…
Published
Nov 4, 2026
View

Performance

5D 20D 120D MTD YTD
NGVT +2.7% -11.6% -9.9% -17.0% +4.3%
SPY +2.6% -1.2% +0.5% -0.2% +10.6%
vs SPY +0.1% -10.4% -10.4% -16.8% -6.3%

Capital returns

Buyback program · as of Sep 30, 2026
Authorized
$500.00M
Spent (derived)
$327.80M
Remaining
$172.20M
Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1653477 CUSIP 45688C107 13F (30d) 280 filings 245 filers Visit website Investor relations